Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Faculty Members have conducted research related to the Targeting Bruton’S Tyrosine Kinase (Btk) As a Signaling Pathway in Immune-Mediated Diseases: From Molecular Mechanisms to Leading Treatments
Mohammad Hossein Yazdi
Mohammad Hossein Yazdi

Associate Professor of Pharmaceutical Biotechnology

Biotechnology Research Center

Tehran University of Medical Sciences

Related Documents
1. Looking Into the Toxicity Potential and Clinical Benefits of Tyrosine Kinase Inhibitors (Tkis), Encyclopedia of Toxicology# Fourth Edition: Volume 1-9 (2023)
All Documents
5. Candidiasis in Breast Cancer: Tumor Progression or Not?, Iranian Journal of Basic Medical Sciences (2024)
14. Looking Into the Toxicity Potential and Clinical Benefits of Tyrosine Kinase Inhibitors (Tkis), Encyclopedia of Toxicology# Fourth Edition: Volume 1-9 (2023)
30. Potential Vaccines for Treating Crohn's Disease, Iranian Biomedical Journal (2020)